These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8572606)

  • 1. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.
    Ino K; Goto S; Kosaki A; Nomura S; Asada E; Misawa T; Furuhashi Y; Mizutani S; Tomoda Y
    Biotherapy; 1991; 3(4):351-7. PubMed ID: 1786199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
    Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
    J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bestatin on syngeneic tumors in mice.
    Abe F; Shibuya K; Uchida M; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1984 Jan; 75(1):89-94. PubMed ID: 6586596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of three new human gestational choriocarcinoma cell lines.
    Sugiura M; Goto S; Saito M; Kato S; Hattori S; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1447-54. PubMed ID: 3171272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Telomerase RNA antisense oligonucleotides inhibit growth of human choriocarcinoma xenograft in nude mice].
    Chen LL; Zheng W; Chen XJ; Wan L; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):90-2. PubMed ID: 15946546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory and therapeutic properties of bestatin in mice.
    Talmadge JE; Lenz BF; Pennington R; Long C; Phillips H; Schneider M; Tribble H
    Cancer Res; 1986 Sep; 46(9):4505-10. PubMed ID: 2942238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU; Bosslet K; Sedlacek HH
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
    Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
    Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of drug sensitivity on newly established three choriocarcinoma cell lines].
    Okayama Y; Goto S; Fan C; Ueda S; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):17-23. PubMed ID: 3819510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of bestatin and thiorphan in mice.
    Kowalski J; Belowski D; Madej A; Herman ZS
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):265-71. PubMed ID: 8744646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity.
    Ino K; Goto S; Okamoto T; Nomura S; Nawa A; Isobe K; Mizutani S; Tomoda Y
    Jpn J Cancer Res; 1994 Sep; 85(9):927-33. PubMed ID: 7961121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
    Bruley-Rosset M; Payelle B; Rappaport H
    J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
    Cole LA; Dai D; Butler SA; Leslie KK; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):145-50. PubMed ID: 16631920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.